SCHEMBL25947253

SCHEMBL25947253

c1ccc(-c2ccc(-c3cccc(-c4ccc(-c5nc(-c6ccc7c(c6)sc6ccccc67)nc(-c6cccc7oc8ccccc8c67)n5)cc4)c3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
PLA2G10 O15496 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 1/20 0.33
LIMK1 P53667 1/20 0.33
PIM3 Q86V86 1/20 0.33
F9 P00740 1/20 0.33
ALOX5 P09917 1/20 0.33
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645977 1.00 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL26711155 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL25459238 0.97 PRKDC (0.35) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL24315477 0.97 MAPT (0.35) ALDH1A1MAPTHPGDSMN1; SMN2RAB9A
SCHEMBL23823560 0.96 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL19802534 0.96 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL22876255 0.96 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL23821586 0.96 MMP12 (0.35) PLA2G2APLA2G4AALDH1A1MAPTHPGD
SCHEMBL26725630 0.96 PIM3 (0.36) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT
SCHEMBL26709917 0.96 PIM3 (0.36) PLA2G2APLA2G4APLA2G10ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4212526-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 PLA2G2A 3794/4885PLA2G4A 4035/4885PLA2G10 4291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.